Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

NCT01162486 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Tuberculosis, Pulmonary

Interventions

DRUG: Rifampin & midazolam
DRUG: rifapentine & midazolam
DRUG: rifapentine & midazolam
DRUG: rifapentine & midazolam
DRUG: rifapentine and midazolam
DRUG: rifapentine and midazolam

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]